Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 100370101000001114 | Midazolam + Lidocaine (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 100370201000001119 | Midazolam + Lidocaine | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Midazolam + Lidocaine | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Midazolam + Lidocaine | Is a | Product containing midazolam | false | Inferred relationship | Existential restriction modifier | ||
| Midazolam + Lidocaine | Is a | Product containing lidocaine | false | Inferred relationship | Existential restriction modifier | ||
| Midazolam + Lidocaine | Has active ingredient | Midazolam | true | Inferred relationship | Existential restriction modifier | ||
| Midazolam + Lidocaine | Has active ingredient | Lidocaine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules | Is a | True | Midazolam + Lidocaine | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR